Latest News
Centrus Energy Eyes $120M Supplier Acquisition to Strengthen Nuclear Fuel Chain
Centrus Energy (LEU) is in advanced talks to buy an unnamed U.S. supplier for about $120 million, a valuation below 0.8x sales. Yet, without profit or cash flow data, the true cost remains unclear.
Greenwave's Preferred Deal Could Flood Shares by 86%
Greenwave Technology Solutions (GWAV) raised $3.75M via preferred stock, potentially adding 715,649 common shares—86.3% of its count—raising dilution concerns.
GlucoTrack's $11.6M Deal Yields Only $4.5M Cash, Dilution Looms
GlucoTrack's $11.6M financing brings only $4.5M new cash, with the rest from converted debt and discount. Shares fell 21% on dilution concerns.
SharonAI Leadership Shift: COO Transition Preserves Founder's Equity Stake
SharonAI disclosed leadership changes, with co-founder Leece keeping 151,219 RSUs as Burns becomes COO. Contract runs to 2027, stock up 5%.
Netflix Pulls Plug on 'Ransom Canyon' as Audience Slips
Netflix has canceled 'Ransom Canyon' after two seasons, following a 41% drop in three-week viewership. The move underscores the streamer's focus on content ROI.
Belden's Ruckus Buy: Margin Boost Meets $1.8B Debt Burden
Belden's Ruckus acquisition boosts margins but adds $1.8B debt, cutting net income. BDC stock faces deleveraging test.
T3 Defense Bridges to Next Funding with $3M Loan
T3 Defense has taken a $3 million bridge loan to fund operations until its planned $10 million preferred stock sale closes. The loan matures December 8 or earlier if financing is secured.
Volato's AI Merger Dilutes SOAR Shareholders to 5% Stake
Volato Group's merger with Alignment Engine leaves SOAR shareholders with a 5% stake, while a $7.5M note complicates valuation.
Fly-E Appoints New CEO Amid Unresolved Executive Transition Questions
Fly-E Group appointed Qiang Chen as CEO following Lisa Fan's sudden resignation, but filings conflict on who held top roles. Stock dropped 17% before the news.
Acadia Pharma Governance Overhaul Approved, No Cash for Shareholders
Acadia Pharmaceuticals' derivative settlement brings four years of governance reforms, not cash payouts. A federal court will consider final approval in January 2027.
DeFi Development Expands CHAD Preferred ATM to $300M for Solana Treasury
DeFi Development Corp. has launched an at-the-market program for 30 million CHAD preferred shares, potentially raising $300M to fund Solana (SOL) acquisitions and strategic initiatives.
Daily Journal Authorizes Share Repurchase, Revises Voting Structure
Daily Journal Corp. authorizes a 2.5% share buyback and ends cumulative voting, replacing it with proxy access and other governance changes.